BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 9, 2005
View Archived Issues
On Heels Of VX-950 Data, Vertex Gathers Up $153M
Vertex Pharmaceuticals Inc. sold 11.75 million shares to raise gross proceeds of $152.8 million, the second highest amount of any biotech follow-on or initial public offering this year. (BioWorld Today)
Read More
Panel Confirms Positive Data For Erbitux In Phase III Trial
Read More
Osiris Brings In $50M To Fund Stem Cell-Based Therapeutics
Read More
Gates Foundation Awards $22M Grant To Hookworm Research
Read More
Correction
Read More
Other News To Note
Read More